Business Description
OKYO Pharma Ltd
ISIN : GG00BMFG5F62
Share Class Description:
OKYO: ADRDescription
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.83 | |||||
| Equity-to-Asset | -0.4 | |||||
| Debt-to-Equity | -1.08 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -482.2 | |||||
| 3-Year EPS without NRI Growth Rate | -573.1 | |||||
| 3-Year FCF Growth Rate | -457.2 | |||||
| 3-Year Book Growth Rate | -41.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.83 | |||||
| 9-Day RSI | 61.3 | |||||
| 14-Day RSI | 55.96 | |||||
| 6-1 Month Momentum % | -10.24 | |||||
| 12-1 Month Momentum % | 18.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.72 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.4 | |||||
| Shareholder Yield % | -18.97 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -7265.69 | |||||
| ROA % | -353.01 | |||||
| ROIC % | -1597.63 | |||||
| ROC (Joel Greenblatt) % | -219783.33 | |||||
| ROCE % | -7206.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3.64 | |||||
| EV-to-Forward-EBIT | -1.56 | |||||
| EV-to-EBITDA | -3.64 | |||||
| EV-to-FCF | -6.24 | |||||
| Earnings Yield (Greenblatt) % | -27.47 | |||||
| FCF Yield % | -15.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OKYO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OKYO Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.164 | ||
| Beta | 0 | ||
| Volatility % | 80.49 | ||
| 14-Day RSI | 55.96 | ||
| 14-Day ATR ($) | 0.102165 | ||
| 20-Day SMA ($) | 1.41967 | ||
| 12-1 Month Momentum % | 18.25 | ||
| 52-Week Range ($) | 0.9201 - 3.25 | ||
| Shares Outstanding (Mil) | 33.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OKYO Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OKYO Pharma Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OKYO Pharma Ltd Frequently Asked Questions
What is OKYO Pharma Ltd(OKYO)'s stock price today?
The current price of OKYO is $1.50. The 52 week high of OKYO is $3.25 and 52 week low is $0.92.
When is next earnings date of OKYO Pharma Ltd(OKYO)?
The next earnings date of OKYO Pharma Ltd(OKYO) is 2024-08-15 Est..
Does OKYO Pharma Ltd(OKYO) pay dividends? If so, how much?
OKYO Pharma Ltd(OKYO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers